TORL BioTherapeutics

TORL

TORL BioTherapeutics develops antibody-based immunotherapies and drug conjugates to treat patients with various solid tumours and haematological cancers.

Adcytherix

This biopharmaceutical company develops novel antibody-drug conjugates to treat various forms of cancer for patients with high unmet clinical needs.

Profound Bio

This clinical-stage biotechnology company develops antibody-drug conjugates and targeted therapies for patients with solid tumors and hematological malignancies.

Emergence Therapeutics

This biopharmaceutical company develops antibody-drug conjugate immunotherapies to treat solid tumours for patients with high unmet medical needs.

Callio Therapeutics

The company develops multi-payload antibody-drug conjugates to treat cancer patients.

BioAtla®

This biopharmaceutical company develops conditionally active antibody therapeutics for the treatment of various cancers in clinical-stage patients.

Adcendo

This clinical-stage biotechnology company develops antibody-drug conjugates to treat patients with various types of cancer and high unmet medical needs.

Ona Therapeutics

This company develops antibody-drug conjugates to treat patients with advanced and metastatic cancers which have become resistant to existing therapies.